BIOTECHFLOW Direct Isolation from biomass of antibodies and therapeutics from lab to cGMP kg_Phase IV production from virus isolate Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: The isolation and purification of antibodies, therapeutic proteins, nviruses, viral antigens, RNA, T cells, direct from unclarified biomass by nExpanded Bed Adsorption Chromatography (EBA)nfrom laboratory to full scale kg cGMP (Phase IV) commercial productionnApplicable to high viscosity complex biomasses such as human plasma thus currently very relevant for antibodies raised against COVID-19 (a Coronavirus) at kg commercial (Phase IV) cGMP production scale. nnBiotechflow specialises in unique
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)